Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThis change adjusts how the Chilean Valparaíso location is presented (e.g., region wording) while keeping the same city/address line for that site. It also reflects an automated site version/revision update without altering the study’s scientific or participant-relevant details.SummaryDifference0.2%

- Check17 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded Padova, Italy 35128 and removed Padua, Italy 35128 from the study locations.SummaryDifference0.0%

- Check39 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the study locations.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision tag on the page changed from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.